bexarotene has been researched along with Leukopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, T; Iwatsuki, K; Kawai, K; Kiyohara, E; Matsushita, S; Nagatani, T; Ohtsuka, M; Saida, T; Setoyama, M; Sugaya, M; Tani, M; Tokura, Y; Tsuboi, R; Yonekura, K | 1 |
| Dahut, W; Geiser, R; Gill, GM; Hawkins, MJ; Jaunakais, D; Loewen, G; Marshall, JL; Ness, E; Rizvi, NA; Truglia, JA; Ulm, EH | 1 |
2 trial(s) available for bexarotene and Leukopenia
| Article | Year |
|---|---|
Long-term efficacy and safety of bexarotene for Japanese patients with cutaneous T-cell lymphoma: The results of a phase 2 study (B-1201).
Topics: Adult; Antineoplastic Agents; Bexarotene; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypothyroidism; Japan; Leukopenia; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Male; Mycosis Fungoides; Neoplasm Staging; Neutropenia; Skin Neoplasms; Time Factors; Young Adult | 2019 |
A Phase I study of LGD1069 in adults with advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Bexarotene; Female; Headache; Humans; Leukopenia; Male; Middle Aged; Neoplasm Staging; Neoplasms; Tetrahydronaphthalenes; Treatment Outcome | 1999 |